Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Anthem Biosciences Ltd.
₹779.25
₹765.20
₹819.65
₹579.15
₹873.50
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 582.50 | 416.58 | 552.23 | 538.01 | 478.98 |
| Operating Expense | 315.51 | 253.53 | 326.57 | 342.58 | 280.87 |
| Operating Profit | 266.99 | 163.05 | 225.66 | 195.43 | 198.11 |
| Depreciation | 26.28 | 26.75 | 23.92 | 22.61 | 20.99 |
| Interest | 1.58 | 1.13 | 2.23 | 1.61 | 2.10 |
| Tax | 89.06 | 37.98 | 54.87 | 50.60 | 90.28 |
| Net Profit | 211.66 | 112.12 | 198.43 | 148.34 | 122.56 |
₹779.25
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
| Held By | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 74.7 | 74.7 | 74.7 |
| FII | 1.7 | 1.4 | 1.3 |
| DII | 7.2 | 7.6 | 11.5 |
| Public | 16.4 | 16.3 | 12.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.5 L | 3.24 L | 46.31% |
| Week | 1.66 L | 3.29 L | 50.32% |
| 1 Month | 2.3 L | 4.03 L | 57.11% |
| 6 Month | 4.18 L | 5.78 L | 72.40% |
Best results last week in YoY net profit and revenue growth
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,149 | ₹1,874 | ₹1,737 | ₹2,580.90 | ₹176.40 |
| % Change | 2.10% | 1.05% | 1.57% | 3.54% | 1.83% |
| Revenue TTM (₹ Cr) | ₹2,192.49 | ₹1,421.59 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹348.91 | ₹-73.80 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 69.40 | -290.10 | 35.60 | 55.80 | -71.90 |
| 1 Year Return | 52.37 | 14.63 | 61.15 | 0.77 | -14.16 |
| ROCE | 18.38 | 0.59 | 25.65 | 13.27 | 2.29 |
Acutaas Chemicals Ltd.
₹ 2897.10
+0.37%
Gland Pharma Ltd.
₹ 2216.00
-1.56%
Laurus Labs Ltd.
₹ 1358.00
+0.97%
Alkem Laboratories Ltd.
₹ 5440.00
-0.55%
Biocon Ltd.
₹ 434.00
+1.37%
Divi's Laboratories Ltd.
₹ 6880.50
-0.46%
Ajanta Pharma Ltd.
₹ 3184.00
-1.98%
Zydus Lifesciences Ltd.
₹ 1040.30
+2.10%
Glenmark Pharmaceuticals Ltd.
₹ 2370.00
-1.49%
Wockhardt Ltd.
₹ 1613.00
-0.44%
Aurobindo Pharma Ltd.
₹ 1520.40
+0.50%
Natco Pharma Ltd.
₹ 1157.00
+2.31%
Sun Pharmaceutical Industries Ltd.
₹ 1880.00
-0.12%
Neuland Laboratories Ltd.
₹ 16630.00
-0.95%
Ipca Laboratories Ltd.
₹ 1641.90
-0.86%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2165.00
-0.30%
AstraZeneca Pharma India Ltd.
₹ 8601.00
-1.09%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2348.00
-1.73%
Pfizer Ltd.
₹ 4680.00
-2.20%
Abbott India Ltd.
₹ 27450.00
-1.24%
Torrent Pharmaceuticals Ltd.
₹ 4450.00
-0.23%
Lupin Ltd.
₹ 2282.80
-0.20%
Dr. Reddy's Laboratories Ltd.
₹ 1320.90
-1.07%
Cipla Ltd.
₹ 1400.10
-0.69%
By signing up I certify terms, conditions & privacy policy